Goldman Sachs Group Inc Day One Biopharmaceuticals, Inc. Transaction History

Goldman Sachs Group Inc

  • $613 Billion
  • Q4 2024

A detailed history of Goldman Sachs Group Inc transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 472,239 shares of DAWN stock, worth $4.58 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
472,239
Previous 1,774,307 73.38%
Holding current value
$4.58 Million
Previous $24.7 Million 75.79%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
SELL
$12.46 - $16.39 $16.2 Million - $21.3 Million
-1,302,068 Reduced 73.38%
472,239 $5.98 Million
Q3 2024

Nov 14, 2024
SELL
$12.72 - $16.03 $1.64 Million - $2.06 Million
-128,801 Reduced 6.77%
1,774,307 $24.7 Million
Q2 2024

Aug 13, 2024
SELL
$12.03 - $17.69 $2.82 Million - $4.15 Million
-234,383 Reduced 10.97%
1,903,108 $26.2 Million
Q1 2024

May 15, 2024
BUY
$13.56 - $17.46 $252,785 - $325,489
18,642 Added 0.88%
2,137,491 $35.3 Million
Q4 2023

Feb 13, 2024
BUY
$9.68 - $15.37 $4.58 Million - $7.26 Million
472,654 Added 28.71%
2,118,849 $30.9 Million
Q3 2023

May 14, 2024
SELL
$11.22 - $14.86 $5.3 Million - $7.02 Million
-472,654 Reduced 22.31%
1,646,195 $20.2 Million
Q3 2023

Nov 14, 2023
SELL
$11.22 - $14.86 $8.37 Million - $11.1 Million
-746,328 Reduced 31.19%
1,646,195 $20.2 Million
Q2 2023

May 14, 2024
BUY
$11.74 - $14.47 $1.28 Million - $1.58 Million
109,187 Added 4.78%
2,392,523 $28.6 Million
Q2 2023

Aug 14, 2023
BUY
$11.74 - $14.47 $1.28 Million - $1.58 Million
109,187 Added 4.78%
2,392,523 $28.6 Million
Q1 2023

May 14, 2024
BUY
$12.75 - $23.41 $6.57 Million - $12.1 Million
515,234 Added 29.14%
2,283,336 $30.5 Million
Q1 2023

May 11, 2023
BUY
$12.75 - $23.41 $6.57 Million - $12.1 Million
515,234 Added 29.14%
2,283,336 $30.5 Million
Q4 2022

May 14, 2024
BUY
$18.77 - $22.0 $806,359 - $945,120
42,960 Added 2.49%
1,768,102 $38 Million
Q4 2022

Feb 13, 2023
BUY
$18.77 - $22.0 $806,359 - $945,120
42,960 Added 2.49%
1,768,102 $38 Million
Q3 2022

May 14, 2024
SELL
$16.44 - $26.57 $2.78 Million - $4.5 Million
-169,395 Reduced 8.94%
1,725,142 $34.6 Million
Q3 2022

Nov 10, 2022
SELL
$16.44 - $26.57 $2.78 Million - $4.5 Million
-169,395 Reduced 8.94%
1,725,142 $34.6 Million
Q2 2022

May 14, 2024
SELL
$5.72 - $17.9 $1.28 Million - $4.02 Million
-224,312 Reduced 10.59%
1,894,537 $33.9 Million
Q2 2022

Aug 15, 2022
BUY
$5.72 - $17.9 $10.7 Million - $33.4 Million
1,863,325 Added 5969.9%
1,894,537 $33.9 Million
Q1 2022

May 16, 2022
BUY
$9.12 - $17.47 $60,793 - $116,455
6,666 Added 27.16%
31,212 $310,000
Q4 2021

Feb 14, 2022
BUY
$15.65 - $26.33 $384,144 - $646,296
24,546 New
24,546 $414,000

Others Institutions Holding DAWN

# of Institutions
176
Shares Held
77.8M
Call Options Held
139K
Put Options Held
253K
View Full List

About Day One Biopharmaceuticals, Inc.

DAWN Quotes by TradingView
  • Ticker DAWN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,461,104
  • Market Cap $713M
  • Description
  • Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...
More about DAWN
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email